Relay Therapeutics Inc. Common Stock vs Viavi Solutions Inc. Common Stock — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.89 (market cap $3.82B), while Viavi Solutions Inc. Common Stock trades at $45.43 (market cap $10.85B). The key difference: Viavi Solutions Inc. Common Stock is far larger — about 2.8× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is more actively traded (4,332,079 versus 4,281,289). Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| RLAY | VIAV | |
|---|---|---|
Market Cap | $3.82B | $10.85B |
Volume | 4,332,079 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $20.75 | $55.33 |
52-Week Low | $6.03 | $12.27 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $2.93B | $10.89B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →